OPRK1 and breast cancer: In this study, kappa opioid receptor 1 knockdown blocked BC cell viability and migration, reduced protein and gene expression of vimentin, snail, N-cadherin and matrix metalloproteinase 2, increased the expression of E-cadherin, and favored the inactivation of the PI3K/Akt signaling pathway [268].